• CBX2-Mediated Interferon Suppression and Tumor Immune Evasio

  2026-04-22

  This study uncovers a noncanonical role of CBX2 in suppressing tumor immunogenicity by repressing interferon signaling through a CBX2–RACK1–HDAC1 complex, independent of canonical PRC2 activity. These findings reveal new epigenetic mechanisms of immune evasion, providing novel targets and biomarkers for immunotherapy.

• A Yeast-Based System for Sensitive mTOR Inhibitor Discovery

  2026-04-22

  This study introduces a drug-sensitized yeast platform that enhances the sensitivity and throughput of mTOR inhibitor screening, enabling detection of TOR1-dependent growth inhibition at far lower compound concentrations than previously possible. The system's specificity is validated by both positive and negative controls, providing a robust tool for drug discovery and mechanistic research in aging and cancer biology.

• HA-LNPs Enable Transdermal PTEN mRNA Immunotherapy for Melan

  2026-04-21

  This study introduces hyaluronate-conjugated lipid nanoparticles (HA-LNPs) as an innovative vehicle for transdermal delivery of PTEN mRNA in melanoma models. By enabling efficient, non-invasive gene delivery and tumor targeting, HA-LNPs restore tumor suppressor function and potentiate immune-mediated tumor clearance, with broad implications for localized mRNA-based cancer immunotherapy.

• Ciclopirox Induces ER Stress and Apoptosis in NSCLC Cells

  2026-04-21

  Lu et al. (2022) reveal that ciclopirox suppresses non-small cell lung cancer (NSCLC) cell proliferation and metastasis by disrupting cellular bioenergetics and activating endoplasmic reticulum (ER) stress-mediated apoptosis. Their integrated molecular and functional assays provide mechanistic clarity for drug repurposing strategies in NSCLC.

• Applied Amikacin Sulfate: Intracellular Delivery & In Vivo U

  2026-04-20

  Explore how Amikacin Sulfate enables targeted, high-efficacy research against non-tuberculous mycobacterial infections. This guide details stepwise experimental workflows, advanced troubleshooting, and translational insights for maximizing both intracellular and in vivo performance, leveraging APExBIO’s trusted quality.

• Clozapine N-oxide (CNO): Chemogenetic Actuator for Neuroscie

  2026-04-20

  Clozapine N-oxide (CNO) is a biologically inert metabolite used to selectively modulate neuronal activity via DREADDs in neuroscience research. It offers precise, reversible GPCR signaling without significant off-target effects in mammalian systems. APExBIO supplies high-purity CNO (SKU A3317) for validated chemogenetic workflows.

• Rotenone as a Precision Mitochondrial Complex I Inhibitor: P

  2026-04-19

  Explore how Rotenone, a mitochondrial Complex I inhibitor, uniquely enables both mechanistic and translational research into mitochondrial dysfunction, apoptosis, and autophagy pathways. This in-depth analysis delivers advanced protocol guidance and integrates new immunometabolic insights for neurodegenerative disease models.

• Paclitaxel (Taxol): Optimized Workflows for Cancer Research

  2026-04-18

  Paclitaxel (Taxol) stands at the forefront of cancer research as a microtubule polymer stabilizer, enabling precise cell cycle and apoptosis studies. This article details advanced experimental workflows, actionable troubleshooting strategies, and insights from the latest nanomedicine research—empowering scientists to unlock the full potential of Paclitaxel in oncology and cell biology.

• A Drug-Sensitized Yeast System for Enhanced mTOR Inhibitor D

  2026-04-17

  The referenced study introduces a genetically engineered, drug-sensitized yeast platform that dramatically increases the sensitivity and throughput of identifying mTOR inhibitors. This system enables lower-dose screening, enhances selectivity for TOR1-dependent compounds, and provides a robust tool for rapid drug discovery in aging and cancer research.

• Bedaquiline: Mechanistic Insights and Translational Impact i

  2026-04-16

  Explore how Bedaquiline, a diarylquinoline antibiotic, uniquely disrupts Mycobacterium tuberculosis energy metabolism and impairs cancer stem cell bioenergetics. This article provides mechanistic depth and practical assay guidance, expanding beyond protocol summaries.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress: Ne

  2026-04-15

  This study demonstrates that the cytoskeleton, particularly microfilaments, is essential for autophagy induced by mechanical compression in human cells. The findings clarify mechanisms of mechanotransduction and highlight distinct roles of cytoskeletal components in autophagic response, with implications for research on cell survival and therapeutic interventions.

• Applied Workflows Using 2'3'-cGAMP (sodium salt) in STING Re

  2026-04-14

  2'3'-cGAMP (sodium salt) from APExBIO empowers precise activation of the cGAS-STING pathway, enabling robust assessment of innate immune responses and translational immunotherapy models. This article distills practical workflows, data-backed parameters, and troubleshooting strategies to elevate experimental reproducibility and interpretability.

• ERK5 and ERK1/2 Pathways in Vitamin D3-Induced AML Different

  2026-04-13

  This study elucidates the distinct roles of ERK5 and ERK1/2 MAPK pathways in the terminal differentiation of acute myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. The findings highlight ERK5 as critical for cell cycle arrest during differentiation, while ERK1/2 is required for broad myeloid marker expression, offering new mechanistic insights for combination therapeutic strategies in AML.

• LMO2–LDB1 Complex Drives AML Progression via Transcriptional

  2026-04-13

  This study elucidates how the interaction between LMO2 and LDB1 promotes acute myeloid leukemia (AML) progression by supporting leukemic cell proliferation and survival. The findings reveal mechanistic insights into transcriptional regulation in AML, suggesting the LMO2/LDB1 complex as a potential therapeutic target.

• A Drug-Sensitized Yeast Platform for mTOR Inhibitor Discover

  2026-04-12

  Breen et al. (2025) introduce a drug-sensitized yeast system that drastically improves the sensitivity for detecting mTOR/TOR inhibitors, enabling rapid and cost-effective screening of candidate molecules. This method demonstrates a 200–250-fold increase in sensitivity over wild-type backgrounds, providing a valuable tool for geroprotective and anti-cancer drug discovery.

16038 records 1/1070 page Next 12345 下5页 Last page